359 related articles for article (PubMed ID: 22788994)
21. Sulfamates and their therapeutic potential.
Winum JY; Scozzafava A; Montero JL; Supuran CT
Med Res Rev; 2005 Mar; 25(2):186-228. PubMed ID: 15478125
[TBL] [Abstract][Full Text] [Related]
22. Design of [(2-pyrimidinylthio)acetyl]benzenesulfonamides as inhibitors of human carbonic anhydrases.
Čapkauskaitė E; Zubrienė A; Baranauskienė L; Tamulaitienė G; Manakova E; Kairys V; Gražulis S; Tumkevičius S; Matulis D
Eur J Med Chem; 2012 May; 51():259-70. PubMed ID: 22440859
[TBL] [Abstract][Full Text] [Related]
23. Carbonic anhydrase IX inhibitors in cancer therapy: an update.
Supuran CT; Winum JY
Future Med Chem; 2015; 7(11):1407-14. PubMed ID: 26230880
[TBL] [Abstract][Full Text] [Related]
24. New chemotypes acting as isozyme-selective carbonic anhydrase inhibitors with low affinity for the offtarget cytosolic isoform II.
Carta F; Vullo D; Maresca A; Scozzafava A; Supuran CT
Bioorg Med Chem Lett; 2012 Mar; 22(6):2182-5. PubMed ID: 22365761
[TBL] [Abstract][Full Text] [Related]
25. Unexpected nanomolar inhibition of carbonic anhydrase by COX-2-selective celecoxib: new pharmacological opportunities due to related binding site recognition.
Weber A; Casini A; Heine A; Kuhn D; Supuran CT; Scozzafava A; Klebe G
J Med Chem; 2004 Jan; 47(3):550-7. PubMed ID: 14736236
[TBL] [Abstract][Full Text] [Related]
26. Probing the surface of human carbonic anhydrase for clues towards the design of isoform specific inhibitors.
Pinard MA; Mahon B; McKenna R
Biomed Res Int; 2015; 2015():453543. PubMed ID: 25811028
[TBL] [Abstract][Full Text] [Related]
27. Structure-based screening for the discovery of new carbonic anhydrase VII inhibitors.
De Luca L; Ferro S; Damiano FM; Supuran CT; Vullo D; Chimirri A; Gitto R
Eur J Med Chem; 2014 Jan; 71():105-11. PubMed ID: 24287559
[TBL] [Abstract][Full Text] [Related]
28. Carbonic anhydrase inhibitors. Sulfonamide diuretics revisited--old leads for new applications?
Temperini C; Cecchi A; Scozzafava A; Supuran CT
Org Biomol Chem; 2008 Jul; 6(14):2499-506. PubMed ID: 18600270
[TBL] [Abstract][Full Text] [Related]
29. Antiobesity carbonic anhydrase inhibitors: a literature and patent review.
Scozzafava A; Supuran CT; Carta F
Expert Opin Ther Pat; 2013; 23(6):725-35. PubMed ID: 23607332
[TBL] [Abstract][Full Text] [Related]
30. Homology modeling and receptor-based 3D-QSAR study of carbonic anhydrase IX.
Tuccinardi T; Ortore G; Rossello A; Supuran CT; Martinelli A
J Chem Inf Model; 2007; 47(6):2253-62. PubMed ID: 17949069
[TBL] [Abstract][Full Text] [Related]
31. 4-Substituted-2,3,5,6-tetrafluorobenzenesulfonamides as inhibitors of carbonic anhydrases I, II, VII, XII, and XIII.
Dudutienė V; Zubrienė A; Smirnov A; Gylytė J; Timm D; Manakova E; Gražulis S; Matulis D
Bioorg Med Chem; 2013 Apr; 21(7):2093-106. PubMed ID: 23394791
[TBL] [Abstract][Full Text] [Related]
32. Carbonic anhydrases: current state of the art, therapeutic applications and future prospects.
Pastorekova S; Parkkila S; Pastorek J; Supuran CT
J Enzyme Inhib Med Chem; 2004 Jun; 19(3):199-229. PubMed ID: 15499993
[TBL] [Abstract][Full Text] [Related]
33. Dithiocarbamates: a new class of carbonic anhydrase inhibitors. Crystallographic and kinetic investigations.
Carta F; Aggarwal M; Maresca A; Scozzafava A; McKenna R; Supuran CT
Chem Commun (Camb); 2012 Feb; 48(13):1868-70. PubMed ID: 22218610
[TBL] [Abstract][Full Text] [Related]
34. Carbonic anhydrase inhibitors as emerging drugs for the treatment of obesity.
Supuran CT
Expert Opin Emerg Drugs; 2012 Mar; 17(1):11-5. PubMed ID: 22335448
[TBL] [Abstract][Full Text] [Related]
35. Exploiting the hydrophobic and hydrophilic binding sites for designing carbonic anhydrase inhibitors.
De Simone G; Alterio V; Supuran CT
Expert Opin Drug Discov; 2013 Jul; 8(7):793-810. PubMed ID: 23627619
[TBL] [Abstract][Full Text] [Related]
36. Anti-infective carbonic anhydrase inhibitors: a patent and literature review.
Capasso C; Supuran CT
Expert Opin Ther Pat; 2013; 23(6):693-704. PubMed ID: 23488877
[TBL] [Abstract][Full Text] [Related]
37. Anticancer carbonic anhydrase inhibitors: a patent review (2008 - 2013).
Monti SM; Supuran CT; De Simone G
Expert Opin Ther Pat; 2013; 23(6):737-49. PubMed ID: 23672415
[TBL] [Abstract][Full Text] [Related]
38. Carbonic anhydrase inhibitors: inhibition of mammalian isoforms I-XIV with a series of substituted phenols including paracetamol and salicylic acid.
Innocenti A; Vullo D; Scozzafava A; Supuran CT
Bioorg Med Chem; 2008 Aug; 16(15):7424-8. PubMed ID: 18579385
[TBL] [Abstract][Full Text] [Related]
39. Carbonic anhydrases--an overview.
Supuran CT
Curr Pharm Des; 2008; 14(7):603-14. PubMed ID: 18336305
[TBL] [Abstract][Full Text] [Related]
40. Carbonic Anhydrase Inhibitors and Epilepsy: State of the Art and Future Perspectives.
Ciccone L; Cerri C; Nencetti S; Orlandini E
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770789
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
